Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Q-Pharm Pty Ltd., Brisbane, Australia
Contact: Study coordinator (Teena Pisarev) · t.pisarev@nucleusnetwork.com.au · +61737072720
Contact: Principal Investigator (Gloria Wong)

Study leads

Weifen Zhou, Dr.
Study Director
Newsoara Biopharma Co., Ltd.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Healthy Adult Participants · Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Grayslake, United States

The Effect of Bifidobacterium Probiotics on Gut Microbiota Changes in Healthy Adults During Short-term Travel Along the Silk Road

Healthy Adult Volunteer

Abroad (travel likely)RecruitingPHASE2

Huangpu, China · George Town, Malaysia